Myeloma Measurable Residual Disease (MRD) Detection, Flow Cytometry
- Laboratory
- Quest Diagnostics
- Test code
- 38287
- Specimen
- Blood
- Fasting
- Not stated
- LOINC
- 108137-1, 19099-1, 19139-5, 31208-2, 49493-0, 55752-0, 57723-9, 8251-1, 92185-8
- Turnaround
- Set up: Daily
Laboratory assay overview
Next-generation flow cytometry (NGFC) is an ultra-sensitive tool for assessing measurable residual disease (MRD) in hematologic malignancies. MRD tests provide crucial prognostic information to clinicians, helping them evaluate treatment response and determine if a patient is in stable remission or relapse.
View complete laboratory reference notes
See Laboratory Report
Quest Diagnostics test directory, test code 38287